Gastrointestinal mucus layer (GIMB) (GIMB)

The gastrointestinal (GI) mucus layer is a complex, viscoelastic hydrogel that serves as the primary innate defense barrier between the luminal environment and the underlying intestinal epithelium. It is predominantly composed of large, highly glycosylated proteins known as mucins, with MUC2 being the primary structural component in the intestine and MUC5AC/MUC6 in the stomach [1.1.1, 1.4.2]. This layer plays a critical role in protecting the mucosa from mechanical stress, digestive enzymes, and pathogenic invasion while simultaneously providing a specialized niche for the commensal microbiota [1.4.1, 1.4.4]. Dysregulation of the mucus layer, such as thinning or altered glycosylation, is a hallmark of inflammatory bowel diseases (IBD) and gastric ulcers, where the loss of barrier function leads to increased permeability and inflammation [1.1.2, 1.5.3]. Conversely, in conditions like cystic fibrosis, the mucus becomes excessively thick and adherent, leading to obstructive complications [1.1.1]. Therapeutically, the mucus layer is targeted by mucoprotective agents like sucralfate, which reinforces the barrier, and mucolytics like N-acetylcysteine that modify its rheological properties [1.3.1, 1.3.4]. Additionally, the layer is a significant factor in drug delivery, where mucoadhesive formulations are designed to prolong residence time for improved oral bioavailability [1.3.1, 1.4.3].

Other names

Gastric mucusIntestinal mucusGastrointestinal mucus barrierMucus gel layer

Mucolysis via cleavage of disulfide bonds in mucin polymers; Mucoprotection through the formation of a physical protective shield over the mucosa; Stimulation of mucin synthesis and secretion from goblet cells; Mucoadhesion to increase drug residence time and absorption.